TP53 and cancer: Overall, 51% of TP53-loss phenocopied tumor samples across all cancer types were not linked with one of the three known causal genes nor a CNA deletion in TP53 itself, suggesting that additional TP53 phenocopying mechanisms are commonly occurring in human tumors.